Gordon Ryan A, Zumbro Emily L, Castleberry Todd J, Sokoloski Matthew L, Brisebois Matthew F, Irvine Christopher J, Duplanty Anthony A, Ben-Ezra Vic
Department of Biology, Drury University, Springfield, MO, USA.
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
BMC Sports Sci Med Rehabil. 2022 Jul 30;14(1):147. doi: 10.1186/s13102-022-00540-z.
Both aerobic exercise and whey protein can improve glucose regulation. The purpose of this study was to investigate how a single bout of vigorous-intensity aerobic exercise and whey protein, independently, as well as when combined, influence glycemia during an oral glucose tolerance test in sedentary, young men.
Healthy males (n = 11) completed four randomized trials: no exercise/no whey protein (R); exercise (EX; walking at 70% VO for 60 min); 50 g of whey protein (W); and exercise combined with 50 g of whey protein (EXW). Each trial included a 75 g oral glucose tolerance test (OGTT) that was completed after an overnight fast. Blood samples were collected over a two-hour period during the OGTT. For EX and EXW, the exercise was performed the evening before the OGTT and the 50 g of whey protein was dissolved in 250 mL of water and was consumed as a preload 30 min prior to the OGTT. For R and EX, participants consumed 250 mL of water prior to the OGTT. Plasma samples were analyzed for glucose, insulin, C-peptide, glucagon, gastric inhibitory peptide (GIP) and glucagon like peptide 1 (GLP-1), and postprandial incremental area under the curve (iAUC) was calculated for each.
Glucose iAUC was reduced during W (- 32.9 ± 22.3 mmol/L) compared to R (122.7 ± 29.8 mmol/L; p < 0.01) and EX (154.3 ± 29.2 mmol/L; p < 0.01). Similarly, glucose iAUC was reduced for EXW (17.4 ± 28.9 mmol/L) compared to R and EX (p < 0.01 for both). There were no differences in iAUC for insulin, C-peptide, GIP, GLP-1, and glucagon between the four trials. Insulin, C-peptide, glucagon, GIP, and GLP-1 were elevated during the whey protein preload period for W and EXW compared to EX and R (p < 0.01). There were no differences for insulin, C-peptide, glucagon, GIP, or GLP-1 between trials for the remaining duration of the OGTT.
Glucose responses during an oral glucose tolerance test were improved for W compared to EX. There were no additional improvements in glucose responses when vigorous-intensity aerobic exercise was combined with whey protein (EXW).
有氧运动和乳清蛋白均可改善血糖调节。本研究旨在调查单次高强度有氧运动和乳清蛋白单独以及联合使用时,对久坐不动的年轻男性口服葡萄糖耐量试验期间血糖的影响。
健康男性(n = 11)完成四项随机试验:无运动/无乳清蛋白(R);运动(EX;以70%VO₂强度步行60分钟);50克乳清蛋白(W);运动加50克乳清蛋白(EXW)。每项试验均包括一次75克口服葡萄糖耐量试验(OGTT),试验在过夜禁食后完成。在OGTT的两小时期间采集血样。对于EX和EXW,运动在OGTT前一晚进行,50克乳清蛋白溶解于250毫升水中,在OGTT前30分钟作为预负荷饮用。对于R和EX,参与者在OGTT前饮用250毫升水。分析血浆样本中的葡萄糖、胰岛素、C肽、胰高血糖素、胃抑肽(GIP)和胰高血糖素样肽1(GLP-1),并计算每个指标的餐后曲线下增量面积(iAUC)。
与R(122.7±29.8 mmol/L;p < 0.01)和EX(154.3±29.2 mmol/L;p < 0.01)相比,W组的葡萄糖iAUC降低(-32.9±22.3 mmol/L)。同样,与R和EX相比,EXW组的葡萄糖iAUC也降低(两者均p < 0.01)。四项试验中胰岛素、C肽、GIP、GLP-1和胰高血糖素的iAUC无差异。与EX和R相比,W组和EXW组在乳清蛋白预负荷期间胰岛素、C肽、胰高血糖素、GIP和GLP-1升高(p < 0.01)。在OGTT的其余时间段内,各试验之间胰岛素、C肽、胰高血糖素、GIP或GLP-1无差异。
与EX相比,W组在口服葡萄糖耐量试验期间的葡萄糖反应得到改善。高强度有氧运动与乳清蛋白联合使用(EXW)时,葡萄糖反应无额外改善。